JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexoff, D. L.
Right arrow Articles by Volkow, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexoff, D. L.
Right arrow Articles by Volkow, N. D.

Reproducibility of 11C-Raclopride Binding in the Rat Brain Measured with the MicroPET R4: Effects of Scatter Correction and Tracer Specific Activity

David L. Alexoff, BSE1, Paul Vaska, PhD2, Douglas Marsteller, MS3, Timofei Gerasimov1, Juan Li, MA4, Jean Logan, PhD1, Joanna S. Fowler, PhD1, Nicholas B. Taintor, MS2, Panayotis K. Thanos, PhD2 and Nora D. Volkow, MD2

1 Chemistry Department, Brookhaven National Laboratory, Upton, New York
2 Medical Department, Brookhaven National Laboratory, Upton, New York
3 Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York
4 Department of Applied Mathematics and Statistics, State University of New York at Stony Brook, Stony Brook, Stony Brook, New York



View larger version (19K):

[in a new window]
 
FIGURE 1. Typical sinogram projections in rat head with 11C-raclopride. (A) Ten minutes after injection. (B) Sixty minutes after injection.

 


View larger version (36K):

[in a new window]
 
FIGURE 2. Test-retest experiments in rat brain with 11C-raclopride. For all graphs, circles represent striatum and diamonds represent cerebellum. %ID/cm3 = percentage of injected dose per cubic centimeter. • and {diamondsuit}, First injection; {circ} and {diamond}, Second injection. (A) First injection, 12.84 MBq (347 µCi; 3.8 nmol/kg raclopride); second injection, 11.91 MBq (322 µCi; 1.9 nmol/kg raclopride). (B) First injection, 7.22 MBq (195 µCi; 1.2 nmol/kg raclopride); second injection, 6.51 MBq (176 µCi; 1.0 nmol/kg raclopride). (C) First injection, 5.99 MBq (162 µCi; 0.5 nmol/kg raclopride); second injection, 13.88 MBq (375 µCi; 1.7 nmol/kg raclopride). (D) Blocking study: first injection, 17.58 MBq (475 µCi; 15 nmol/kg raclopride); second injection, 18.54 MBq (501 µCi; 1 mg/kg or 2,881 nmol/kg raclopride).

 


View larger version (17K):

[in a new window]
 
FIGURE 3. Reproducibility of 11C-raclopride binding in brains of 6 adult rats. •, Mean ROI value in striatum in 6 rats. {diamondsuit}, Mean ROI value in cerebellum of 6 rats. Error bars are ±1 SD of mean. %ID/cm3 = percentage of injected dose per cubic centimeter.

 


View larger version (14K):

[in a new window]
 
FIGURE 4. Effect of raclopride mass on DVR. Receptor occupancy is calculated from injected raclopride mass associated with tracer 11C-raclopride according to Hume et al. (23).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.